TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34426552

Group type: EXPERIMENTAL
Intervention: Multicomponent training program (daily activities, dancing, gardening, sports/games) twice weekly for 3 months
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 63
Study: 33769656

Group type: EXPERIMENTAL
Intervention: Henagliflozin 5 mg
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Henagliflozin 10 mg
Number of subjects: 483

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Henagliflozin 5 mg and 10 mg
Number of subjects: 483
Study: 32876488

Group type: EXPERIMENTAL
Intervention: Causal variant rs3219175 in the promoter region of RETN
Number of subjects: 5621

Group type: COMPARATOR
Intervention: Mendelian randomization analyses
Number of subjects: 5621
Study: 35972485

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Conditioning (RIC) for 10 to 14 days as an adjunct to guideline-based treatment (n=922)
Number of subjects: 1893

Group type: COMPARATOR
Intervention: Guideline-based treatment alone (Control group, n=971)
Number of subjects: 1893

Group type: EXPERIMENTAL
Intervention: Remote Ischemic Conditioning (RIC)
Number of subjects: 1893

Group type: COMPARATOR
Intervention: Guideline-based treatment alone (Control group)
Number of subjects: 1893
Study: 34174137

Group type: EXPERIMENTAL
Intervention: Music during flexible cystoscopy
Number of subjects: 109
Study: 32315696

Group type: EXPERIMENTAL
Intervention: Anodal tDCS delivered at Fp3 site for 10 minutes at 1.5 mA
Number of subjects: 112

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 112
Study: 34654603

Group type: EXPERIMENTAL
Intervention: Piezocision
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no piezocision)
Number of subjects: 22
Study: 34146045

Group type: EXPERIMENTAL
Intervention: Subretinal hyperreflective material (SHRM)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Anti-VEGF therapy with SHRM
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control group (no SHRM)
Number of subjects: 207
Study: 33090112

Group type: EXPERIMENTAL
Intervention: CAir Desk and hybrid digital coaching intervention for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: CAir Desk with usual care for 12 weeks
Number of subjects: 0
Study: 34709526

Group type: EXPERIMENTAL
Intervention: Injectable
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Implant
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Pills
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Condoms
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: No contraception
Number of subjects: 208

Group type: COMPARATOR
Intervention: No method
Number of subjects: 208

Group type: COMPARATOR
Intervention: Sterilization
Number of subjects: 208

Group type: COMPARATOR
Intervention: Natural family planning
Number of subjects: 208

Group type: COMPARATOR
Intervention: Copper IUD
Number of subjects: 208

Group type: COMPARATOR
Intervention: Unknown
Number of subjects: 208
Study: 33970955

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 984

Group type: EXPERIMENTAL
Intervention: Convalescent plasma (CP)
Number of subjects: 984

Group type: COMPARATOR
Intervention: Admission timing
Number of subjects: 984

Group type: COMPARATOR
Intervention: Initial C-reactive protein (CRP) value
Number of subjects: 984
Study: 33207359

Group type: EXPERIMENTAL
Intervention: Lidocaine and Midazolam
Number of subjects: 80

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 80
Study: 34164944

Group type: EXPERIMENTAL
Intervention: Belimumab 10 mg/kg IV plus standard therapy
Number of subjects: 448

Group type: COMPARATOR
Intervention: Placebo plus standard therapy
Number of subjects: 448
Study: 33792001

Group type: EXPERIMENTAL
Intervention: Partial excision of the infrapatellar fat pad (IPFP)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Total excision of the infrapatellar fat pad (IPFP)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups (total and partial excision)
Number of subjects: 72
Study: 32046597

Group type: EXPERIMENTAL
Intervention: Weight-stigmatizing message
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control message
Number of subjects: 0
Study: 35067488

Group type: EXPERIMENTAL
Intervention: 5-hour sleep condition
Number of subjects: 16

Group type: COMPARATOR
Intervention: 7-hour sleep condition
Number of subjects: 16
Study: 33314310

Group type: EXPERIMENTAL
Intervention: Physical activity (PA) interventions, tailored and supervised, varying in type, intensity, duration, and frequency.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Barriers to physical activity (PA)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Preferred forms of PA interventions
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Joint self-instructed and group accompanying PA
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Overall impact of PA on ABC patients
Number of subjects: 18
Study: 33977619

Group type: EXPERIMENTAL
Intervention: Use of medications during pregnancy (multivitamins, analgesics, folic acid)
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Knowledge acquisition from healthcare providers
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Information provided by pharmacists
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Attitudes towards medication use during pregnancy
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Association between nationality and occupation with attitudes about medications
Number of subjects: 434
Study: 32861359

Group type: EXPERIMENTAL
Intervention: AQE + DWR
Number of subjects: 54

Group type: COMPARATOR
Intervention: AQE
Number of subjects: 54
Study: 36455035

Group type: EXPERIMENTAL
Intervention: Working memory training (storage and processing or relational integration)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 171

Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 171
Study: 33250271

Group type: EXPERIMENTAL
Intervention: Patient Concerns Inventory (PCI) fatigue group
Number of subjects: 140

Group type: COMPARATOR
Intervention: Patients with advanced tumors
Number of subjects: 140

Group type: COMPARATOR
Intervention: Patients treated with radiotherapy ± chemotherapy
Number of subjects: 140
Study: 33914418

Group type: EXPERIMENTAL
Intervention: Online e-learning module
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blended e-learning module
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional e-learning module
Number of subjects: 0
Study: 32567372

Group type: EXPERIMENTAL
Intervention: Zizao Yangrong granules (ZYG)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo granules combined with vitamin E ointment (Control)
Number of subjects: 68
Study: 616857406

Group type: EXPERIMENTAL
Intervention: Mobile application social support program via Line, twice per week for 4 weeks after childbirth
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 126
Study: 35279345

Group type: EXPERIMENTAL
Intervention: Bystander intervention program during full implementation
Number of subjects: 15863
Study: 33378515

Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP) at 4-week intervals
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP) at 8-week intervals
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP) at 12-week intervals
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control sites (no MOP)
Number of subjects: 30
Study: 34677118

Group type: EXPERIMENTAL
Intervention: Multi-session exercise program for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (pharmacological treatment only)
Number of subjects: 40
Study: 32738837

Group type: EXPERIMENTAL
Intervention: IV levonadifloxacin 800 mg
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Oral levonadifloxacin 1000 mg
Number of subjects: 500
Study: 32228526

Group type: EXPERIMENTAL
Intervention: Chronic Dental Problems (DPs)
Number of subjects: 575
Study: 34980212

Group type: EXPERIMENTAL
Intervention: On-demand telelactation video calls on personal devices
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Ebook on infant care/usual care
Number of subjects: 2400
Study: 35760393

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 53
Study: 34699954

Group type: EXPERIMENTAL
Intervention: Fluroshield (Dentsply)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: BeautiSealant with S‐PRG (Shofu)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Both materials (FS and BS)
Number of subjects: 56
Study: 36054231

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 6262

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6262
Study: 34092235

Group type: EXPERIMENTAL
Intervention: Long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS)
Number of subjects: 34548

Group type: EXPERIMENTAL
Intervention: Households closer to the lake Zeway and Bulbula river (potential mosquito breeding sites)
Number of subjects: 34548

Group type: EXPERIMENTAL
Intervention: Age group under 5 years
Number of subjects: 34548

Group type: EXPERIMENTAL
Intervention: Age group 5–14 years
Number of subjects: 34548

Group type: EXPERIMENTAL
Intervention: Less educated household head
Number of subjects: 34548

Group type: EXPERIMENTAL
Intervention: House roof made of thatch/leaf
Number of subjects: 34548

Group type: EXPERIMENTAL
Intervention: Distance from breeding sites, educational status, and type of housing
Number of subjects: 34548
Study: 34475155

Group type: COMPARATOR
Intervention: 300 mg secukinumab (pharmacological control group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 75 mg secukinumab (75% dose reduction)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 75 mg secukinumab + novel tasting drink (group 3)
Number of subjects: 120
Study: 32400733

Group type: COMPARATOR
Intervention: Dynamic hip screw (Group A)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Proximal femoral nail (Group B)
Number of subjects: 68
Study: 34900122

Group type: EXPERIMENTAL
Intervention: CPTSD cluster
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: PTSD cluster
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Language acquisition & barriers (one of four PMLD factors)
Number of subjects: 93
Study: 32242820

Group type: EXPERIMENTAL
Intervention: Smartphone-based cognitive behavior therapy (CBT) TBHC intervention for pain self-management, 8 weeks, daily or every other day interaction
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Intention to change behavior
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Working alliance with TBHC SELMA
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Adherence via usage data
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Participants' feedback on app usage
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Acceptance postintervention
Number of subjects: 102

Group type: COMPARATOR
Intervention: Pain-related impairment (primary outcome)
Number of subjects: 102

Group type: COMPARATOR
Intervention: General well-being
Number of subjects: 102

Group type: COMPARATOR
Intervention: Pain intensity
Number of subjects: 102

Group type: COMPARATOR
Intervention: Bond scale of working alliance
Number of subjects: 102
Study: 33464959

Group type: EXPERIMENTAL
Intervention: e-counseling (motivational and cognitive-behavioral tools for CHF self-care)
Number of subjects: 231

Group type: COMPARATOR
Intervention: e-based conventional CHF self-care education (e-UC)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: e-counseling
Number of subjects: 231

Group type: COMPARATOR
Intervention: e-UC
Number of subjects: 231
Study: 32357239

Group type: EXPERIMENTAL
Intervention: Blood Pressure (BP)
Number of subjects: 3531

Group type: EXPERIMENTAL
Intervention: Pulse Wave Velocity (PWV)
Number of subjects: 3531

Group type: EXPERIMENTAL
Intervention: Mendelian Randomization (One-sample)
Number of subjects: 3531

Group type: EXPERIMENTAL
Intervention: Mendelian Randomization (Two-sample)
Number of subjects: 3531
Study: 35263650

Group type: EXPERIMENTAL
Intervention: Medication abortions
Number of subjects: 0
Study: 34399198

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 64
Study: 32375715

Group type: EXPERIMENTAL
Intervention: Ebola-related tweets (non-joke)
Number of subjects: 72775

Group type: COMPARATOR
Intervention: Tweets with misinformation
Number of subjects: 72775
Study: 33563104

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ) 400 mg two times daily
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 32576320

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (NR-BJ)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (ND-BJ)
Number of subjects: 15
Study: 35263688

Group type: EXPERIMENTAL
Intervention: Nutritional therapy according to an algorithm based on individualized nutritional requirements
Number of subjects: 1181

Group type: COMPARATOR
Intervention: Standard hospital food
Number of subjects: 1181

Group type: EXPERIMENTAL
Intervention: Nutritional therapy
Number of subjects: 1181
Study: 33217814

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 0

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 0
Study: 32845782

Group type: EXPERIMENTAL
Intervention: Tetravalent Influenza Vaccine (TetIV)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Trivalent Influenza Vaccine (TriIV)
Number of subjects: 306
Study: 32621903

Group type: EXPERIMENTAL
Intervention: Endoscopic and minimally invasive surgical therapies for GERD
Number of subjects: 22
Study: 32598809

Group type: EXPERIMENTAL
Intervention: Supervised exercise training at the outpatient rehabilitation center (n=53)
Number of subjects: 114

Group type: COMPARATOR
Intervention: No exercise training at the outpatient hospital (n=61)
Number of subjects: 114
Study: 35910816

Group type: EXPERIMENTAL
Intervention: Paracervical block (4 ml of lidocaine at 4 and 8 o’clock positions)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Conscious sedation (30 mg pentazocine and 10 mg diazepam)
Number of subjects: 162
Study: 33507202

Group type: EXPERIMENTAL
Intervention: Jilin ginseng root (GS) supplementation for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 35820510

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AT) for 8 weeks
Number of subjects: 33
Study: 34187382

Group type: EXPERIMENTAL
Intervention: 60 mg/kg/day vitamin C as a continuous infusion for 96 hours
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline in the same volume for 96 hours (control)
Number of subjects: 80
Study: 35870924

Group type: EXPERIMENTAL
Intervention: ACLR with stump preservation (60 cases)
Number of subjects: 120

Group type: COMPARATOR
Intervention: ACLR after total resection of the tibial stump (60 cases)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: ACLR with stump preservation
Number of subjects: 120

Group type: COMPARATOR
Intervention: ACLR after total resection of the tibial stump
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 33783553

Group type: EXPERIMENTAL
Intervention: Vitamin K1 (2.5 mg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32187390

Group type: EXPERIMENTAL
Intervention: Exercise intervention for 4 weeks
Number of subjects: 65

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 65
Study: 35138986

Group type: EXPERIMENTAL
Intervention: Short-Term Psychodynamic Psychotherapy (STPP)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Self-criticism
Number of subjects: 157
Study: 34091060

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 62
Study: 35129421

Group type: EXPERIMENTAL
Intervention: Two Way Prayer Meditation (TWPM)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 134
Study: 32374820

Group type: EXPERIMENTAL
Intervention: Genetically predicted increase in TSH levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hashimoto's thyroiditis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal range thyroid function
Number of subjects: 0
Study: 33269487

Group type: EXPERIMENTAL
Intervention: Fresh frozen plasma (FFP) transfusion every 48 hours
Number of subjects: 31

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 31
Study: 34558214

Group type: EXPERIMENTAL
Intervention: Intraoperative amino acid (AA) infusion
Number of subjects: 27
Study: 36370961

Group type: EXPERIMENTAL
Intervention: Turmeric/piperine (3 g turmeric + 2 mg piperine/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Turmeric (3 g/day)
Number of subjects: 0
Study: 33197609

Group type: EXPERIMENTAL
Intervention: 12-month online behavioral lifestyle intervention (BLI) with adjunct components
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Virtual reality for BLI skills training
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Interactive video feedback
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Tailored intervention to promote physical activity
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Skills for dysregulated eating
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Social support combined with friendly competition
Number of subjects: 384
Study: 34684324

Group type: EXPERIMENTAL
Intervention: High-Fat Diet (HFD: 60E% from fat)
Number of subjects: 15

Group type: COMPARATOR
Intervention: High-Carbohydrate Diet (HCD: 60E% from carbohydrates)
Number of subjects: 15
Study: 34671099

Group type: EXPERIMENTAL
Intervention: 0.2 ml 24% oral sucrose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.2 ml 30% oral dextrose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 33258776

Group type: EXPERIMENTAL
Intervention: BetaMe/Melon program
Number of subjects: 215
Study: 35307296

Group type: EXPERIMENTAL
Intervention: Screws
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: TighRope® Knotless
Number of subjects: 68
Study: 34605040

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation and laughter therapy for 40 minutes per session for 3-4 sessions
Number of subjects: 141

Group type: COMPARATOR
Intervention: Routine care (Control Group)
Number of subjects: 141
Study: 36190694

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 239
Study: 33934094

Group type: EXPERIMENTAL
Intervention: High-sn-2-palmitate formula
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 57

Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 57
Study: 35208555

Group type: EXPERIMENTAL
Intervention: Arthrocen 300 mg/day
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 33525438

Group type: EXPERIMENTAL
Intervention: Caffeinated beverage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-caffeinated placebo
Number of subjects: 0
Study: 34362713

Group type: EXPERIMENTAL
Intervention: CGA with corresponding interventions
Number of subjects: 322

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 322
Study: 32618656

Group type: EXPERIMENTAL
Intervention: Allogenic Fecal Microbiota Transplantation (FMT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Autologous Fecal Microbiota Transplantation (FMT)
Number of subjects: 21
Study: 36007534

Group type: EXPERIMENTAL
Intervention: Amitriptyline supplemented with pregabalin (A-P)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Pregabalin supplemented with amitriptyline (P-A)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Duloxetine supplemented with pregabalin (D-P)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: D-P vs A-P
Number of subjects: 140

Group type: COMPARATOR
Intervention: P-A vs A-P
Number of subjects: 140

Group type: COMPARATOR
Intervention: P-A vs D-P
Number of subjects: 140
Study: 32204554

Group type: COMPARATOR
Intervention: Migratens® Group (nutraceutical treatment with coenzyme Q10, vitamin D, alpha‐lipoic acid, magnesium, and tryptophan)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acupuncture Group (acupuncture treatment according to traditional Chinese medicine principles)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (Migratens® and Acupuncture)
Number of subjects: 60
Study: 35638762

Group type: EXPERIMENTAL
Intervention: Polidocanol foam sclerotherapy (SP)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Doppler-guided hemorrhoidal artery ligation with recto-anal repair (HAL-RAR)
Number of subjects: 46
Study: 33048581

Group type: EXPERIMENTAL
Intervention: PEPPER system
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control (standard bolus calculator)
Number of subjects: 54
Study: 36134849

Group type: EXPERIMENTAL
Intervention: Surgical Assessment Tool (SAT) administered at remote hospitals
Number of subjects: 497492
Study: 33562729

Group type: EXPERIMENTAL
Intervention: 5 g of specific collagen peptides (CP‐G)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo group (P‐G)
Number of subjects: 180
Study: 35542991

Group type: EXPERIMENTAL
Intervention: Aducanumab high dose (10 mg/kg target dose)
Number of subjects: 3285

Group type: EXPERIMENTAL
Intervention: Aducanumab low dose (3 or 6 mg/kg target dose)
Number of subjects: 3285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3285
Study: 32785036

Group type: EXPERIMENTAL
Intervention: Phytosterol (2 g of free‐phytosterols nanoparticles daily for six months)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 202
Study: 34542900

Group type: EXPERIMENTAL
Intervention: Nomogram integrating tumor extension, surgery type, radiotherapy, and chemotherapy
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Multivariable Cox analysis
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Nomogram validation
Number of subjects: 267